Synergistic Anti-Biofilm Activity of Klanceng Honey and Probiotics against Candida albicans

Budhi Setiawan, Masfufatun Masfufatun, Lusiani Tjandra, Kartika Ishartadiati

Abstract


Candida albicans is a common cause of fungal infections, especially in hospitals. Biofilm formation by this fungus is a significant problem as it leads to increased drug resistance and complications in treatment. The biofilm's extracellular matrix protects the fungal cells, making it difficult for antifungal drugs to penetrate and clear the infection. Aim: This study investigates the potential of honey and probiotic formulations to inhibit the biofilm matrix formation in Candida albicans. Result: Klanceng honey showed the strongest inhibition of Candida albicans biofilm formation, reducing it by 89.39% (OD = 0.34 ± 0.10), compared to yogurt (29.43%, OD = 2.25 ± 0.16) and Yakult (67.95%, OD = 1.02 ± 0.25) (p < 0.05). When mixed with yogurt in a 5:1:2 ratio (honey:yogurt: water), Klanceng honey reduced biofilm formation by 84.92% (OD = 0.50 ± 0.12). Manuka and Melifera honey in the same ratio also showed strong inhibition, reducing biofilm formation by 77.84% (OD = 0.73 ± 0.08) and 90.52% (OD = 0.31 ± 0.07), respectively. This performance exceeded fluconazole’s, which achieved a 65.52% reduction (OD = 1.14 ± 0.02). For all three honey types, the 4:1:3 and 2:1:5 ratios (honey:Yakult: water) were more effective, with reductions of up to 80.96% for Melifera and 75.64% for Klanceng (p < 0.05). Conclusion: This research suggests that honey and probiotic formulations hold promise as natural alternatives in combating Candida albicans infections. The study found that the ratio of honey to probiotics in the formulations significantly influenced their effectiveness.

Keywords


Klanceng; honey; Yogurt; probiotic; Antibiofilm

Full Text:

PDF

References


Acaroz, U., Kurek-Gorecka, A., Olczyk, P., Tas, N., Ali, A., Paramanya, A., ... & Jin, X. (2024). The role of bee products in the control of antimicrobial resistance and biofilm formation. Kafkas Universitesi Veteriner Fakultesi Dergisi, (2)

Alvarez, L., Kumaran, K. S., Nitha, B., & Sivasubramani, K. (2024). Evaluation of biofilm formation and antimicrobial susceptibility (drug resistance) of Candida albicans isolates. Brazilian Journal of Microbiology, 1-12

Chamtouri, M., Merghni, A., Miranda-Cadena, K., Sakly, N., Gaddour, N., de Los Reyes-Gavilán, C. G., ... & Quindós, G. (2024). Characterization of Yeast Isolated from the Gut Microbiota of Tunisian Children with Autism Spectrum Disorder. Journal of Fungi, 10(11), 730

de Almeida, B. L., Arcieri, V. C., Razente, D. M., Freire, M. P., Guimarães, T., Araújo, E. D. M. P. A. D., ... & Magri, M. M. C. (2024). Intra?Abdominal Candidiasis in Cancer Patients: A 10?Year Experience in a Middle?Income Country. Mycoses, 67(10), e13807

Kreitmann, L., Blot, S., & Nseir, S. (2024). Invasive fungal infections in non-neutropenic patients. Intensive Care Medicine, 1-5

Luca, L., Pauliuc, D., & Oroian, M. (2024). Honey microbiota, methods for determining the microbiological composition and the antimicrobial effect of honey–A review. Food Chemistry: X, 101524

Machado, A., Zamora-Mendoza, L., Alexis, F., & Álvarez-Suarez, J. M. (2023). Use of plant extracts, bee-derived products, and probiotic-related applications to fight multidrug-resistant pathogens in the post-antibiotic era. Future Pharmacology, 3(3), 535-567

Makled, A. F., Ali, S. A., Labeeb, A. Z., Salman, S. S., Shebl, D. Z., Hegazy, S. G., & Sabal, M. S. (2024). Characterization of Candida species isolated from clinical specimens: insights into virulence traits, antifungal resistance and molecular profiles. BMC microbiology, 24(1), 388

Oliva, A., & Venditti, M. (2024). Invasive Candidiasis in Surgery. In Infections in Surgery: Prevention and Management (pp. 107-116). Cham: Springer Nature Switzerland

Saeed, N. K., Almusawi, S., & Al-Beltagi, M. (2024). Candidemia chronicles: Retrospective analysis of candidemia epidemiology, species distribution, and antifungal susceptibility patterns in Bahrain. World Journal of Virology, 13(4)

?anl?, K., Arslanta?, E., Ceylan, A. N., Öncel, B., Özkorucu, D., & Özkan Karagenç, A. (2024). Candidemia in Pediatric-Clinic: Frequency of Occurrence, Candida Species, Antifungal Susceptibilities, and Effects on Mortality (2020–2024). Diagnostics, 14(20), 2343

Sun, C., Zhu, L., Yang, L., Tian, Z., Jiao, Z., Huang, M., ... & Guo, G. (2024). Antimicrobial peptide AMP-17 induces protection against systemic candidiasis and interacts synergistically with fluconazole against Candida albicans biofilm. Frontiers in Microbiology, 15, 1480808

Waykar, R., & Kumarapillai, S. Antifungal Drug resistance in Candida albicans: Identifying Novel Targets for the Development of Effective Antifungal Agents




DOI: https://doi.org/10.14421/biomedich.2025.141.123-127

Refbacks

  • There are currently no refbacks.




Copyright (c) 2025 Budhi Setiawan, Masfufatun, Lusiani Tjandra, Kartika Ishartadiati



Biology, Medicine, & Natural Product Chemistry
ISSN 2089-6514 (paper) - ISSN 2540-9328 (online)
Published by Sunan Kalijaga State Islamic University & Society for Indonesian Biodiversity.

CC BY NC
This work is licensed under a CC BY-NC